Global COVID-19 Sample Collection Kits Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global COVID-19 Sample Collection Kits Market Research Report 2024
COVID-19 Sample Collection Kits include nasopharyngeal and oropharyngeal types in this report.
According to MRA Research’s new survey, global COVID-19 Sample Collection Kits market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole COVID-19 Sample Collection Kits market research.
Key companies engaged in the COVID-19 Sample Collection Kits industry include Thermo Fisher Scientific, QIAGEN, Siemens Healthineers, Abbott, Shimadzu, Cepheid, Bosch Healthcare, Assay Genie and COPAN Diagnostics Inc, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of COVID-19 Sample Collection Kits were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole COVID-19 Sample Collection Kits market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global COVID-19 Sample Collection Kits market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher Scientific
QIAGEN
Siemens Healthineers
Abbott
Shimadzu
Cepheid
Bosch Healthcare
Assay Genie
COPAN Diagnostics Inc
Lucence
BD
Everlywell
Roche
BGI
Sansure
Liferiver Bio-Tech
Zhuhai Livzon Diagnostics Inc
Vazyme
Geneodx
Wondfo
Maccura Biotechnology Co
Wuhan Easy Diagnosis Biomedicine Co
Da An Gene Co
Shanghai BioGerm Medical Biotechnology Co
Jiangsu Bioperfectus Technologies
Bestnovo
Biology and Science
Segment by Type
Nasopharyngeal Sample Collection Kit
Oropharyngeal Sample Collection Kit
Hospitals
Clinics
At-home
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The COVID-19 Sample Collection Kits report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRA Research’s new survey, global COVID-19 Sample Collection Kits market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole COVID-19 Sample Collection Kits market research.
Key companies engaged in the COVID-19 Sample Collection Kits industry include Thermo Fisher Scientific, QIAGEN, Siemens Healthineers, Abbott, Shimadzu, Cepheid, Bosch Healthcare, Assay Genie and COPAN Diagnostics Inc, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of COVID-19 Sample Collection Kits were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole COVID-19 Sample Collection Kits market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global COVID-19 Sample Collection Kits market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
QIAGEN
Siemens Healthineers
Abbott
Shimadzu
Cepheid
Bosch Healthcare
Assay Genie
COPAN Diagnostics Inc
Lucence
BD
Everlywell
Roche
BGI
Sansure
Liferiver Bio-Tech
Zhuhai Livzon Diagnostics Inc
Vazyme
Geneodx
Wondfo
Maccura Biotechnology Co
Wuhan Easy Diagnosis Biomedicine Co
Da An Gene Co
Shanghai BioGerm Medical Biotechnology Co
Jiangsu Bioperfectus Technologies
Bestnovo
Biology and Science
Segment by Type
Nasopharyngeal Sample Collection Kit
Oropharyngeal Sample Collection Kit
Segment by Application
Hospitals
Clinics
At-home
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The COVID-19 Sample Collection Kits report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source